| Typicality: | 0.387 |
| Saliency: | 0.322 |
| for liver cancer | 4 | other |
| quickly | 2 | manner |
| after passing the mouse model stage | 2 | temporal |
| compound → be tested in → human | 8 |
| compound → be tested on → human | 4 |
| compound → be tested in → patient | 3 |
| negative | neutral | positive |
| 0.072 | 0.688 | 0.240 |
| Raw frequency | 15 |
| Normalized frequency | 0.322 |
| Modifier score | 0.500 |
| Perplexity | 64.628 |